Lumos Pharma Total Liabilities

Lumos Pharma (LUMO) currently reports a total liabilities of $13M as of September 2024. That compares with $12M in the prior-year period — up 2.3% year over year. Use the charts on this page to explore Lumos Pharma's total liabilities history and peer comparisons.

Lumos Pharma's total liabilities increased from $12M to $13M — a 2.3% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lumos Pharma reported $13M in total liabilities as of September 2024. That compares with $12M in the prior-year period — up 2.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lumos Pharma, and consider following LUMO for alerts when major investors trade the stock.

Lumos Pharma is classified in the Healthcare sector. On total liabilities, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LUMO with unrelated industries.